Back to Top Skip to main content

Call for 2020 Military Health System Research Symposium abstracts open

Navy Rear Adm. Darin K. Via, deputy chief, Readiness and Health, Bureau of Medicine and Surgery, meets with Mr. Mike Galarneau, director, Operational Readiness & Health, Naval Health Research Center, during poster presentations while attending MHSRS 2019. (U.S. Navy photo by John Marciano) Navy Rear Adm. Darin K. Via, deputy chief, Readiness and Health, Bureau of Medicine and Surgery, meets with Mr. Mike Galarneau, director, Operational Readiness & Health, Naval Health Research Center, during poster presentations while attending MHSRS 2019. (U.S. Navy photo by John Marciano)

Recommended Content:

Research and Innovation

FALLS CHURCH, VA. — The 2020 Military Health System Research Symposium Call for Abstracts is open now and will close on March 25, 2020.

MHSRS is the Department of Defense’s premier scientific meeting and addresses the unique medical needs of the Warfighter. The symposium is a collaborative environment for military medical care providers with deployment experience, DoD scientists, academia, international partners, and industry to exchange information on research advancements.

Conference programming will focus in four areas: Warfighter Medical Readiness, Expeditionary Medicine, Warfighter Performance, and Return to Duty.

The MHSRS website is the best source of information on the 2020 MHSRS Call for Abstracts, and includes the 2020 Breakout Sessions and instructions on how to submit an abstract.

The 2020 MHSRS Call for Abstracts will NOT be extended past the closing date. Persons planning to submit abstracts should plan accordingly to respond by March 25, 2020 with the required associated documentation.

The location and date of the 2020 MHSRS are yet to be determined. Details will be posted on the MHSRS website and communicated when available.

More than 3,500 people attended the 2019 MHSRS meeting. Attendees participated in a diverse array of panels and workshops covering topics on combat casualty care, military operational medicine including psychological health and resilience, clinical and rehabilitative medicine, medical simulation, and military infectious diseases. In addition, the MHSRS featured an awards ceremony honoring individual and team research accomplishments, and recognized the meeting’s outstanding poster and Young Investigator presentations.

Readers are encouraged to spread the word about the MHSRS Call for Abstracts to encourage a robust and diverse forum to advance the mission of the MHS and military medicine.

You also may be interested in...

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

Showing results 1 - 2 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.